Cargando…
Bruton's Agammaglobulinemia and COVID-19
During the SARS-CoV-2 global pandemic, many patients who have co-morbid conditions are considered high risk for morbidity and mortality; however, those who are immunodeficient are at higher risk of becoming seriously ill. In this article, we present a 26-year old male with a history of X-linked agam...
Autores principales: | Hovey, Justin G, Tolbert, Denise, Howell, Druhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769814/ https://www.ncbi.nlm.nih.gov/pubmed/33391934 http://dx.doi.org/10.7759/cureus.11701 |
Ejemplares similares
-
Correction: Bruton's Agammaglobulinemia and COVID-19
por: Hovey, Justin G, et al.
Publicado: (2021) -
Vegetative Skin Lesions in Patient with Bruton's Agammaglobulinemia
por: Fidanzi, Cristian, et al.
Publicado: (2023) -
X-linked Agammaglobulinemia Presenting with Multiviral Pneumonia
por: Arroyo-Martinez, Yadis M, et al.
Publicado: (2020) -
Presentation of a case of Bruton type primary agammaglobulinemia in Guinea
por: Condé, Kaba, et al.
Publicado: (2020) -
Case report: Evolution of pulmonary manifestations and virological markers in critical COVID-19 infection in Bruton’s agammaglobulinemia
por: Rise, Nina, et al.
Publicado: (2022)